Florida AG sues insulin and GLP-1 makers, PBMs over alleged antitrust collusion

The Florida attorney general sued the largest makers of insulin and GLP-1 drugs, along with pharmacy benefit manager giants and rebate companies, on Tuesday, alleging unlawful collusion in an antitrust case.

Detected & updated continuously · Source: Nebula

Story subjects

Florida Attorney Generalinsulin and GLP-1 manufacturerspharmacy benefit managersGLP-1 drugs

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula